Table 1.
Attribute | Attribute description | Attribute levels |
---|---|---|
Effectiveness | Percentage reduction of the number of painful inflammatory lesions on your skin |
25% 50% 75% 100% |
Pain reduction | Reduction of pain (on a scale ranging from 0 to 10) |
Small pain relief (1 point) Moderate pain relief (3 points) Almost complete pain relief (6 points) |
Duration of treatment benefit | The duration in which the treatment provides the proposed effectiveness and pain relief |
6 months 12 months 24 months |
Risk of mild side effect | Annual risk of experiencing a mild side effect while taking the treatment |
100 people out of 1000 (10%) 300 people out of 1000 (30%) 500 people out of 1000 (50%) |
Risk of serious infection | Annual risk of experiencing a serious infection while taking the treatment |
1 person out of 1000 (0.1%) 10 people out of 1000 (1%) 30 people out of 1000 (3%) |
Mode of administration | How the treatment is provided to you |
Oral tablet, once every day Subcutaneous injection, once every 2 weeks at home or in a clinic Intravenous injection, once every 4 weeks in a clinic or hospital setting |